491 related articles for article (PubMed ID: 28501315)
1. Endovascular stenting for end-stage lung cancer patients with superior vena cava syndrome post first-line treatments - A single-center experience and literature review.
Kuo TT; Chen PL; Shih CC; Chen IM
J Chin Med Assoc; 2017 Aug; 80(8):482-486. PubMed ID: 28501315
[TBL] [Abstract][Full Text] [Related]
2. Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting.
Leung ST; Sung TH; Wan AY; Leung KW; Kan WK
Hong Kong Med J; 2015 Oct; 21(5):426-34. PubMed ID: 26139689
[TBL] [Abstract][Full Text] [Related]
3. Brachiocephalic-superior vena cava metallic stenting in malignant superior vena cava obstruction.
Lau KY; Tan LT; Wong WW; Lee AS
Ann Acad Med Singap; 2003 Jul; 32(4):461-5. PubMed ID: 12968550
[TBL] [Abstract][Full Text] [Related]
4. [Observation of endovascular stent insertion for non-small cell lung cancer patients with superior vena cava syndrome].
Li F; Sun X; Liang S; Jiang S; Mao L
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):47-51. PubMed ID: 25877319
[TBL] [Abstract][Full Text] [Related]
5. A retrospective stenting study on superior vena cava syndrome caused by lung cancer.
Wei S; Liu J; Li X; Song Z; Dong M; Zhao H; Zhao Q; Chen G; Chen J
Thorac Cancer; 2020 Jul; 11(7):1835-1839. PubMed ID: 32438532
[TBL] [Abstract][Full Text] [Related]
6. Stent placement for the treatment of malignant superior vena cava syndrome - a single-center series of 56 patients.
Sobrinho G; Aguiar P
Arch Bronconeumol; 2014 Apr; 50(4):135-40. PubMed ID: 24360084
[TBL] [Abstract][Full Text] [Related]
7. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome.
Lanciego C; Pangua C; Chacón JI; Velasco J; Boy RC; Viana A; Cerezo S; García LG
AJR Am J Roentgenol; 2009 Aug; 193(2):549-58. PubMed ID: 19620456
[TBL] [Abstract][Full Text] [Related]
8. Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancer.
Calsina Juscafresa L; Gil Bazo I; Grochowicz L; Páramo Alfaro M; López-Picazo González JM; Moreno Jiménez M; Bilbao Jaureguizar JI
Hosp Pract (1995); 2017 Aug; 45(3):70-75. PubMed ID: 28618844
[TBL] [Abstract][Full Text] [Related]
9. Endovascular stenting as a first choice for the palliation of superior vena cava syndrome.
Kim YI; Kim KS; Ko YC; Park CM; Lim SC; Kim YC; Park KO; Yoon W; Kim YH; Kim JK; Ahn SJ
J Korean Med Sci; 2004 Aug; 19(4):519-22. PubMed ID: 15308841
[TBL] [Abstract][Full Text] [Related]
10. Stent therapy for malignant superior vena cava syndrome: should be first line therapy or simple adjunct to radiotherapy.
Chatziioannou A; Alexopoulos T; Mourikis D; Dardoufas K; Katsenis K; Lazarou S; Koutoulidis V; Ladopoulos Ch; Vlachos L
Eur J Radiol; 2003 Sep; 47(3):247-50. PubMed ID: 12927670
[TBL] [Abstract][Full Text] [Related]
11. Endovascular Management of SVC Syndrome due to Fibrosing Mediastinitis-A Feasibility and Safety Analysis.
Majumdar S; Shoela R; Kim DJ; Ramaswamy R; Mani N; Salter A; Akinwande O
Vasc Endovascular Surg; 2018 Apr; 52(3):202-206. PubMed ID: 29433409
[TBL] [Abstract][Full Text] [Related]
12. [Stenting for superior vena cava obstruction associated with lung cancer: monocentric study].
Pierre MC; Chabbert V; Lozano S; Bigay-Game L; Lévêque N; Desloques L; Otal P; Rousseau H; Didier A; Mazières J
Rev Mal Respir; 2009 Sep; 26(7):744-50. PubMed ID: 19953016
[TBL] [Abstract][Full Text] [Related]
13. The role of self-expanding vascular stent in superior vena cava syndrome for advanced tumours.
Irace L; Martinelli O; Gattuso R; Mingoli A; Fiori E; Alunno A; Di Girolamo A; Crocetti D; Sapienza P
Ann R Coll Surg Engl; 2021 Apr; 103(4):296-301. PubMed ID: 33682470
[TBL] [Abstract][Full Text] [Related]
14. Subacute and chronic benign superior vena cava obstructions: endovascular treatment with self-expanding metallic stents.
Qanadli SD; El Hajjam M; Mignon F; de Kerviler E; Rocha P; Barré O; Chagnon S; Lacombe P
AJR Am J Roentgenol; 1999 Jul; 173(1):159-64. PubMed ID: 10397119
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter stenting of superior vena cava obstruction after pediatric heart transplantation: A single-center experience assessing risk factors and outcomes.
Salavitabar A; Flyer JN; Torres AJ; Richmond ME; Crystal MA; Turner ME; Chai P; Zuckerman WA
Pediatr Transplant; 2018 Nov; 22(7):e13267. PubMed ID: 29992703
[TBL] [Abstract][Full Text] [Related]
16. Retrospective study in 23 patients of the self-expanding sinus-XL stent for treatment of malignant superior vena cava obstruction caused by non-small cell lung cancer.
Mokry T; Bellemann N; Sommer CM; Heussel CP; Bozorgmehr F; Gnutzmann D; Kortes NA; Kauczor HU; Radeleff B; Stampfl U
J Vasc Interv Radiol; 2015 Mar; 26(3):357-65. PubMed ID: 25638748
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous stenting of superior vena cava syndrome: treatment outcome in patients with benign and malignant etiology.
Barshes NR; Annambhotla S; El Sayed HF; Huynh TT; Kougias P; Dardik A; Lin PH
Vascular; 2007; 15(5):314-21. PubMed ID: 17976332
[TBL] [Abstract][Full Text] [Related]
18. A new nitinol stent for use in superior vena cava syndrome. Initial clinical experience.
Andersen PE; Midtgaard A; Brenøe AS; Elle B; Duvnjak S
J Cardiovasc Surg (Torino); 2015 Dec; 56(6):877-81. PubMed ID: 26212865
[TBL] [Abstract][Full Text] [Related]
19. Endovascular stenting of nonmalignant superior vena cava syndrome.
Sheikh MA; Fernandez BB; Gray BH; Graham LM; Carman TL
Catheter Cardiovasc Interv; 2005 Jul; 65(3):405-11. PubMed ID: 15945106
[TBL] [Abstract][Full Text] [Related]
20. Covered stent placement for the treatment of malignant superior vena cava syndrome: is unilateral covered stenting safe and effective?
Cho Y; Gwon DI; Ko GY; Ko HK; Kim JH; Shin JH; Yoon HK; Sung KB
Korean J Radiol; 2014; 15(1):87-94. PubMed ID: 24497797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
